Exir Danesh Asia

Exir Danesh Asia is a specialized pharmaceutical company headquartered in Tehran, Iran, dedicated to the development and manufacturing of high-tech generic medicines. The firm focuses on therapeutic areas with high clinical demand, such as oncology, neurology, and autoimmune diseases, by producing complex small molecule formulations. Their product portfolio includes several advanced kinase inhibitors and immunomodulators, providing cost-effective alternatives to expensive branded specialty drugs. Exir Danesh Asia maintains state-of-the-art manufacturing facilities that comply with international Good Manufacturing Practice (GMP) standards. Through its commitment to research and development, the company aims to enhance patient access to critical treatments within the Iranian and regional healthcare markets.